Humpuss Maritim Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Humpuss Maritim Internasional Tbk. trades at Rp147 (market cap 2.64T, 18.01M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Humpuss Maritim Internasional Tbk. is far larger — about 16× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Humpuss Maritim Internasional Tbk. is more actively traded (18.01M versus 62.5K). Which is the better fit depends on your goals.
| HUMI | OBAT | |
|---|---|---|
Market Cap | 2.64T | 164.65B |
Volume | 18.01M | 62.5K |
Lot | 180.11K | 625 |
Turnover | 2.63B | 15.03M |
Average Price | 145.94 | 240.55 |
Value | 2.63B | 15.03M |
Indicative Equilibrium Price | 147 | 238 |
Indicative Equilibrium Volume | 14.79K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Humpuss Maritim Internasional Tbk. (the Company) is a limited liability company incorporated under the laws of the Republic of Indonesia by virtue of Notarial Deed No. 21 dated September 29, 2016 of Martina, S.H., Notary in Jakarta. The Company change its name from PT MISI Hutama Internasional to PT Humpuss Maritim Internasional. The Company has started its commercial operation since December 2016. Parent entity ofthe Company is PT Humpuss Transportasi Kimia and ultimate parent of the Company is PT Humpuss Intermoda Transportasi Tbk. The Company’s controlling party is H. Hutomo Mandala Putra, SH.
Read more on HUMI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →